PERNILLE MØRCH FYSIOTERAPI ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.4% 7.2% 9.6% 10.6% 9.0%  
Credit score (0-100)  29 32 25 22 27  
Credit rating  BB BBB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -33.8 -30.1 -35.1 -41.9 -41.2  
EBITDA  -653 -669 -670 -665 -673  
EBIT  -702 -719 -720 -715 -698  
Pre-tax profit (PTP)  155.5 176.3 -8.9 -203.2 77.8  
Net earnings  121.2 136.8 -7.2 -158.7 60.8  
Pre-tax profit without non-rec. items  155 176 -8.9 -203 77.8  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  573 654 589 372 371  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,188 1,261 1,178 990 1,296  

Net Debt  -779 -786 -707 -589 -862  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -33.8 -30.1 -35.1 -41.9 -41.2  
Gross profit growth  -11.1% 10.9% -16.5% -19.3% 1.8%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,188 1,261 1,178 990 1,296  
Balance sheet change%  -15.6% 6.2% -6.6% -16.0% 30.9%  
Added value  -652.5 -668.9 -670.3 -664.9 -673.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -99 -99 -99 -99 -50  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2,075.8% 2,384.3% 2,050.3% 1,705.6% 1,696.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  13.2% 15.9% 6.1% -17.0% 10.4%  
ROI %  29.3% 30.1% 11.6% -37.5% 31.9%  
ROE %  22.4% 22.3% -1.2% -33.0% 16.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  48.3% 51.8% 50.0% 37.5% 28.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  119.3% 117.5% 105.5% 88.5% 128.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.3 1.4 1.3 1.0 1.0  
Current Ratio  1.3 1.4 1.3 1.0 1.0  
Cash and cash equivalent  778.7 786.0 707.4 588.5 862.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  215.8 242.2 207.9 182.9 186.2  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -271.8 -299.1 -288.1 -465.1 -572.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -653 -669 -670 -665 -673  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -653 -669 -670 -665 -673  
EBIT / employee  -702 -719 -720 -715 -698  
Net earnings / employee  121 137 -7 -159 61